File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors

TitleHoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors
Authors
Wong, HYau, TMan, CWEpstein, RJ
KeywordsBreast Cancer
Cancer Staging
Computer Assisted Tomography
Drug Bioavailability
Drug Withdrawal
Hoarseness
Human
Letter
Priority Journal
Side Effect
Signal Transduction
Treatment Response
Upregulation
Voice Change
Issue Date2009
PublisherInforma Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/0284186x.asp
Citation
Acta Oncologica, 2009, v. 48 n. 8, p. 1213-1215 How to Cite?
DOI: http://dx.doi.org/10.3109/02841860902980453
Persistent Identifierhttp://hdl.handle.net/10722/132645
ISSN
0284-186X
2023 Impact Factor: 2.7
2023 SCImago Journal Rankings: 0.783
ISI Accession Number ID
WOS:000272100300019
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorWong, Hen_HK
dc.contributor.authorYau, Ten_HK
dc.contributor.authorMan, CWen_HK
dc.contributor.authorEpstein, RJen_HK
dc.date.accessioned2011-03-28T09:27:21Z-
dc.date.available2011-03-28T09:27:21Z-
dc.date.issued2009en_HK
dc.identifier.citationActa Oncologica, 2009, v. 48 n. 8, p. 1213-1215en_HK
dc.identifier.issn0284-186Xen_HK
dc.identifier.urihttp://hdl.handle.net/10722/132645-
dc.languageengen_US
dc.publisherInforma Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/0284186x.aspen_HK
dc.relation.ispartofActa Oncologicaen_HK
dc.subjectBreast Canceren_US
dc.subjectCancer Stagingen_US
dc.subjectComputer Assisted Tomographyen_US
dc.subjectDrug Bioavailabilityen_US
dc.subjectDrug Withdrawalen_US
dc.subjectHoarsenessen_US
dc.subjectHumanen_US
dc.subjectLetteren_US
dc.subjectPriority Journalen_US
dc.subjectSide Effecten_US
dc.subjectSignal Transductionen_US
dc.subjectTreatment Responseen_US
dc.subjectUpregulationen_US
dc.subjectVoice Changeen_US
dc.titleHoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitorsen_HK
dc.typeArticleen_HK
dc.identifier.emailYau, T: tyaucc@hku.hken_HK
dc.identifier.emailEpstein, RJ: repstein@hku.hken_HK
dc.identifier.authorityYau, T=rp01466en_HK
dc.identifier.authorityEpstein, RJ=rp00501en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.3109/02841860902980453en_HK
dc.identifier.pmid19863234-
dc.identifier.scopuseid_2-s2.0-70350772332en_HK
dc.identifier.hkuros216915-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-70350772332&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume48en_HK
dc.identifier.issue8en_HK
dc.identifier.spage1213en_HK
dc.identifier.epage1215en_HK
dc.identifier.eissn1651-226X-
dc.identifier.isiWOS:000272100300019-
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridWong, H=23089414000en_HK
dc.identifier.scopusauthoridYau, T=23391533100en_HK
dc.identifier.scopusauthoridMan, CW=36956600700en_HK
dc.identifier.scopusauthoridEpstein, RJ=34975074500en_HK
dc.identifier.issnl0284-186X-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats